Screening entire populations for breast and ovarian cancer gene mutations could prevent millions more breast and ovarian cancer cases across the world compared to current clinical practice, according ...
Although hemochromatosis was first described in the 19 th century, John Sheldon's 1934 description of 300 cases remains a landmark publication in defining the clinical characteristics of the disease.